Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Haemophilia A or B
- People whose Factor VIII or Factor IX activity level is between less than 1% and 25%
- People who have complete records of their factor treatment history and bleeding episodes
- People who are currently being treated at one of the participating centres
Who may not be able to join:
- People who have been referred to the trial specifically because they have developed an inhibitor (an immune response that blocks clotting factor treatment)
- People for whom informed consent has not been obtained
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gili Kenet, PhD, MD, The National Hemophilia Center Ministry of Health Sheba Medical Center Ramat Gan, Israel
Phone: +31850299993
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with antibody development to exogenous clotting factors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.